Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor (original) (raw)
References
D'Andrea A . Hematopoietic growth factors and the regulation of differentiative decisions Curr Opin Cell Biol 1994 6: 804–805 ArticleCASPubMed Google Scholar
Miyajima A, Kitamura T, Haroda N, Yokota T, Arai K-I . Cytokine receptors and signal transduction Annu Rev Immunol 1992 10: 295–331 ArticleCASPubMed Google Scholar
Metcalf D . Cellular hematopoiesis in the twentieth century Semin Hematol 1999 36: 5–12 CASPubMed Google Scholar
Yarden Y, Ullrich A . Growth factor receptor tyrosine kinases Ann Rev Biochem 1988 57: 443–478 ArticleCASPubMed Google Scholar
Hanks SK, Quinn AM, Hunter T . The protein kinase family conserved features and deduced phylogeny of the catalytic domains Science 1988 241: 42–52 ArticleCASPubMed Google Scholar
Rosnet O, Birnbaum D . Hematopoietic receptors of class III receptor-type tyrosine kinases Crit Rev Oncog 1993 4: 595–613 CASPubMed Google Scholar
Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin CI . STK-1, the human homolog of Flk-2/FLT-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells Proc Natl Acad Sci USA 1994 91: 459–463 ArticleCASPubMedPubMed Central Google Scholar
Rappold I, Ziegler BL, Kohler I, Marchetto S, Rosnet O, Birnbaum D, Simmons PJ, Zannettino ACW, Hill B, Neu S, Knapp W, Alitalo R, Alitalo K, Ullrich A, Kanz L, Buhring HJ . Functional and phenotypic characterization of cord blood and bone marrow subsets experessing FLT3 (CD135) receptor tyrosine kinase Blood 1997 90: 1111–1125 Google Scholar
Brasel K, Escobar S, Anderberg R, de Vries P, Gruss H-J, Lyman SD . Expression of the Flt3 receptor and its ligand on hematopoietic cells Leukemia 1995 9: 1212–1218 CASPubMed Google Scholar
Gotze KS, Ramirez M, Tabor K, Small D, Matthews W, Civin CI . Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct Blood 1997 91: 1947–1958 Google Scholar
Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P et al. Multi-level effects of Flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors Blood 1995 86: 1661–1670 CASPubMed Google Scholar
Shah AJ, Smogorzewska EM, Hannum C, Crooks GM . Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38− cells and maintains progenitor cells in vitroBlood 1996 87: 3563–3570 CASPubMed Google Scholar
Hirayama F, Lyman SD, Clark SC, Ogawa M . The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors Blood 1995 85: 1762–1768 CASPubMed Google Scholar
Hunte BE, Hudak S, Campbell D, Xu Y, Rennick D . Flk2/Flt3 ligand is a potent cofactor for the growth of primitive B cell progenitors J Immunol 1996 156: 489–496 CASPubMed Google Scholar
Mackaretschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR . Targeted disruption of the Flk2/Flt3 gene leads to deficiencies in primitive hematopoietic progenitors Immunity 1995 3: 146–161 Google Scholar
Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo MG, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F . Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs Nature 1994 368: 643–648 ArticleCASPubMed Google Scholar
McKenna HJ, de Vries P, Brasel K, Lyman SD, Williams DE . Effect of Flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells Blood 1995 86: 3414–3420 Google Scholar
Lyman SD, Jacobsen SEW . c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities Blood 1998 91: 1101–1134 CASPubMed Google Scholar
van der Geer P, Hunter T, Lindberg R . Receptor protein-tyrosine kinases and their signal transduction pathways Annu Rev Cell Biol 1994 10: 251–337 ArticleCASPubMed Google Scholar
Heldin C . Dimerization of cell surface receptors in signal transduction Cell 1995 80: 213–223 ArticleCASPubMed Google Scholar
Turner AM, Lin NL, Issarachai S, Lyman SD, Broudy VC . FLT3 receptor expression on the surface of normal and malignant human hematopoietic cells Blood 1996 88: 3383–3390 CASPubMed Google Scholar
Dosil M, Wang S, Lemischka I . Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells Mol Cell Biol 1993 13: 6572–6585 ArticleCASPubMedPubMed Central Google Scholar
Rottapel R, Turck CW, Casteran N, Liu X, Birnbaum D, Pawson T, Dubreuil P . Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase Oncogene 1994 9: 1755–1765 CASPubMed Google Scholar
Casteran N, Rottapel R, Beslu N, Lecocq E, Birnbaum D, Dubreuil P . Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3 kinase Cell Mol Biol 1994 40: 443–456 CASPubMed Google Scholar
Lavagna-Sevenier C, Marchetto S, Birnbaum D, Rosnet O . FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates Leukemia 1998 12: 301–310 ArticleCASPubMed Google Scholar
Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ, Broxmeyer HE . Essential role of signal transducer and activator of transcription STAT5A but not STAT5B for FLT3-dependent signaling J Exp Med 2000 5: 719–728 Article Google Scholar
Tse K-F, Mukherjee G, Small D . Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation Leukemia 2000 14: 1766–1776 ArticleCASPubMed Google Scholar
Roussel MF, Downing JR, Sherr CJ . Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains Oncogene 1990 5: 25–30 CASPubMed Google Scholar
Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahra H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y . Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines Blood 1995 85: 790–798 CASPubMed Google Scholar
Shtivelman E, Lifshitz B, Gale R, Canaani E . Fused transcript of abl and bcr genes in chronic myelogenous leukaemia Nature 1985 315: 550–4 ArticleCASPubMed Google Scholar
Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DG, Saltman L, Look AT . Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma Science 1994 263: 1281–1284 ArticleCASPubMed Google Scholar
Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lesssrd M, Berger R, Ghysdael J, Bernard OA . A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 1997 278: 1309–1312 ArticleCASPubMed Google Scholar
Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of PDGF receptor β to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 1994 77: 307–316 ArticleCASPubMed Google Scholar
Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG . The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic meylomonocytic leukemia is a transforming protein that self-associates and activates PDGFBR kinase-dependent signaling pathways Proc Natl Acad Sci USA 1996 93: 14845–14850 ArticleCASPubMedPubMed Central Google Scholar
Horiike S, Yokota S, Nakao M, Iwaai T, Sasai Y, Kaneko H, Taniwaki M, Kashima K, Fujii H, Abe T, Misawa S . Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia Leukemia 1997 11: 1442–1446 ArticleCASPubMed Google Scholar
Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T, Missawa S . Internal tandem duplication of the Flt3 gene found in acute myeloid leukemia Leukemia 1996 10: 1911–1918 CASPubMed Google Scholar
Iwai T, Yokota S, Nakao M, Okamoto T, Taniwaki M, Onodera N, Watanabe A, Kikuta A, Tanaka A, Asami K, Sekine I, Mugishima H, Nishimura Y, Koizumi S, Horikoski Y, Mimaya J, Ohta S, Nishikawa K, Iwai A, Shimokawa T, Nakayama M, Kawakami K, Gushiken T, Hyakuna N, Katano N, Tsurusawa M, Fujimoto T . Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia Leukemia 1999 13: 38–43 ArticleCASPubMed Google Scholar
Xu F, Taki T, Yang HW, Hanada R, Hongo T, Ohnishi H, Kobayashi M, Bessho F, Yanagisawa M, Hayashi Y . Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children Br J Haematol 1999 105: 155–162 ArticleCASPubMed Google Scholar
Meshinchi S, Woods W, Stirewalt D, Sweetser D, Buckley J, Tjoa T, Bernstein I, Radich J . Prevalence and prognostic significance of flt3 internal tandem duplication in pediatric acute myeloid leukemia Blood 2001 97: 89–94 ArticleCASPubMed Google Scholar
Kondo M HK, Takahashi Y, Matsumoto K, Fukuda M, Inaba J, Kato K, Kojima S, Matsuyama T . Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia Med Pediatr Oncol 1999 33: 525–529 ArticlePubMed Google Scholar
Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H, Naoe T . Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product Leukemia 1998 12: 1333–1337 ArticleCASPubMed Google Scholar
Hayakawa F TM, Kiyoi H, Tanimoto M, Kitamura T, Saito H, Naoe T . Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines Oncogene 2000 19: 624–631 ArticlePubMed Google Scholar
Mizuki M, Fenski R, Halfter H, Matsumura I, Schmidt R, Muller C, Gruning W, Kratz-Albers K, Serve S, Steur C, Buchner T, Kienast J, Kanakura Y, Berdel W, Serve H . FLT3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways Blood 2000 96: 3907–3914 CASPubMed Google Scholar
Pietsch T, Kyas U, Yakisan E, Hadam M, Ludwig W, Zsebo K et al. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors Blood 1992 80: 1199–1206 CASPubMed Google Scholar
Torres H, Dubrueil P, Falzetti F, Courcoul M, Lopez M, Falcinelli F, Birg F, Tabilio A, Mannoni P . C-fms expression in acute leukemias with complex phenotypes Leukemia 1990 4: 673–677 CASPubMed Google Scholar
Parwaresch MR, Kriepe H, Felgner J, Heidorn K, Jaquet K, Bodewadt-Radzun S, Radzun HJ . M-CSF and M-CSF receptor gene expression in acute myelomonocytic leukemias Leuk Res 1990 14: 27–37 ArticleCASPubMed Google Scholar
Carow CE, Levenstein M, Kaufmann SH, Chen J, Amin S, Rockwell P, Witte L, Borowitz MJ, Civin CI, Small D . Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in humanleukemias Blood 1996 87: 1089–1096 CASPubMed Google Scholar
Birg F, Courcoul M, Rosnet O, Bardin F, Pebusque M, Marchetto S, Tabilio A, Mannoni P, Birnbaum D . Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages Blood 1992 80: 2584–2593 CASPubMed Google Scholar
Rosnet O, Buhring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, Birnbaum D . Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells Leukemia 1996 10: 238–248 CASPubMed Google Scholar
Meierhoff G, Dehmel U, Gruss H-J, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG . Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines Leukemia 1995 9: 1368–1372 CASPubMed Google Scholar
Metcalf D . The roles of stem cell self-renewal and autocrine growth factor production in the biology of myeloid leukemia Cancer Res 1989 49: 2305–2311 CASPubMed Google Scholar
Hawley R . Interleukin-6-type cytokines in myeloproliferativedisease Ann NY Acad Sci 1995 762: 294–307 ArticleCASPubMed Google Scholar
Carroll M, Ohno-Jones S, Tamura S, Buchdunger E, Zimmermann J, Lydon N, Gilliand D, Druker B . CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins Blood 1997 90: 4947–4952 CASPubMed Google Scholar
Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Regenass U, Lydon NB . Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class Proc Natl Acad Sci USA 1995 92: 2558–2562 ArticleCASPubMedPubMed Central Google Scholar
Gazit A, Yaish P, Gilon C, Levitzki A . Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors J Med Chem 1989 32: 2344–2352 ArticleCASPubMed Google Scholar
Gazit A, App H, McMahon G, Chen J, Levitzki A, Bohmer F . Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins J Med Chem 1996 39: 2170–2177 ArticleCASPubMed Google Scholar
Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin C, Waltenberger J, Bohmer F, Levitzki A . Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation Cancer Res 1994 54: 6106–6114 CASPubMed Google Scholar
Osherov N, Levitzki A . Epidermal-growth-factor-dependent activation of the src-family kinases Eur J Biochem 1994 225: 1047–1053 ArticleCASPubMed Google Scholar
Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder, JS, Freeman M, Cohen A, Gazit A, Levitzki A, Roifman CM . Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor Nature 1996 379: 645–648 ArticleCASPubMed Google Scholar
Hara T, Miyajima A . Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis Stem Cells 1996 14: 605–618 ArticleCASPubMed Google Scholar
Darnell JE, Kerr IM, Stark G . Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 1994 264: 1415–1420 ArticleCASPubMed Google Scholar
Fukazawa T, Reedquist K, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoeslon SE, Band H . The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase J Biol Chem 1995 270: 19141–19150 ArticleCASPubMed Google Scholar
Donovan J, Wange R, Langdon W, Samelson L . The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor J Biol Chem 1994 269: 22921–22924 CASPubMed Google Scholar
Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HC . v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas Proc Natl Acad Sci USA 1989 86: 1168–1172 ArticleCASPubMedPubMed Central Google Scholar
Barber DL, Mason JM, Fukazawa T, Reedquist KA, Druker BJ, Band H, D'Andrea AD . Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins Blood 1997 89: 3166–3174 CASPubMed Google Scholar
Solanilla A, Grosset C, Lemervier C, Dupouy M, Mahon F, Schweitzer K, Reiffers J, Weksler B, Ripoche J . Expression of Flt3-ligand by the endothelial cell Leukemia 2000 14: 153–162 ArticleCASPubMed Google Scholar
Lisovsky M, Braun M, Ge Y, Takahira H, Lu L, Savchenko VG, Lyman SD, Broxmeyer HE . Flt3-ligand production by human bone marrow stromal cells Leukemia 1996 10: 1012–1018 CASPubMed Google Scholar
Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M . Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax Blood 1996 88: 3987–3997 CASPubMed Google Scholar
Zhao M, Kiyoi H, Yammamoto Y, Ito M, Towatari M, Omura S, Kitamura T, Ueda T, Saito H, Naoe T . In vivo treatment of mutant FLT3-transformed murine leukemia with tyrosine kinase inhibitor Leukemia 2000 14: 374–378 ArticleCASPubMed Google Scholar
Bryckaert M, Eldor A, Fontenay M, Gazit A, Osherov N, Gilon C, Levitzki A, Tobelem G . Inhibition of platelet-derived growth factor-induced mitogenesis and tyrosine kinase activity in cultured bone marrow fibroblasts by tyrphostins Exp Cell Res 1992 199: 255–261 ArticleCASPubMed Google Scholar
Bilder G, Krawiec J, McVety K, Gazit A, Gilon C, Lyall R, Ziberstein A, Levitzki A, Perrone M, Schreiber A . Tyrphostins inhibit PDGF-induced DNA sythesis and associated early events in smooth muscle cells Am J Physiol 1991 260: 721–730 Article Google Scholar
Kovalenko M, Ronnstrand L, Heldin C-H, Loubtchenkov M, Gazit A, Levitzki A, Bohmer FD . Phosphorylation site-specific inhibition of platelet-derived growth factor B-receptor autophosphorylation by the receptor blocking tyrphostin AG1296 Biochemistry 1997 36: 6260–6269 ArticleCASPubMed Google Scholar
Druker B, Ttamura S, Buchdunger E, Ohno S, Segal G, Fanning S . Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 1996 2: 561–566 ArticleCASPubMed Google Scholar
Kravtsov V, Greer J, Whitlock J, Koury M . Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias Blood 1998 92: 968–980 CASPubMed Google Scholar
Koopman G, Reutelingsperger C, Kuijten G, Keehnen R, Pals S, van Oers M . Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 1994 84: 1415–1420 CASPubMed Google Scholar
Martin S, Reutelingsperger C, McGahon A, Rader J, van Schie R, LaFace D, Green D . Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl J Exp Med 1995 182: 1545–1556 ArticleCASPubMed Google Scholar
Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL . Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N Engl J Med 2001 344: 1031–1037 ArticleCASPubMed Google Scholar
Levis M, Tse K-F, Smith BD, Garrett E, and Small D . A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to AML blasts harboring FLT3/ITD mutations Blood 2001 98 (in press):